메뉴 건너뛰기




Volumn 368, Issue 24, 2013, Pages 2294-2302

Acute high-altitude illnesses

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; DEXAMETHASONE; IBUPROFEN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PHOSPHODIESTERASE V INHIBITOR; SALMETEROL; TADALAFIL;

EID: 84878890136     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp1214870     Document Type: Article
Times cited : (384)

References (50)
  • 3
    • 0017109687 scopus 로고
    • The incidence, importance, and prophylaxis of acute mountain sickness
    • Hackett PH, Rennie D, Levine HD. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 1976;2:1149-55.
    • (1976) Lancet , vol.2 , pp. 1149-1155
    • Hackett, P.H.1    Rennie, D.2    Levine, H.D.3
  • 10
    • 84878875350 scopus 로고    scopus 로고
    • High altitude - An exploration of human adaptation
    • Hornbein TF, Schoene R, eds. New York: Marcel Dekker
    • Bärtsch P, Roach R. High altitude - an exploration of human adaptation. In: Hornbein TF, Schoene R, eds. Lung biology in health and disease. Vol. 161. New York: Marcel Dekker, 2001:731-76.
    • (2001) Lung Biology in Health and Disease , vol.161 , pp. 731-776
    • Bärtsch, P.1    Roach, R.2
  • 11
  • 12
    • 50249099182 scopus 로고    scopus 로고
    • Microhemorrhages in nonfatal high-altitude cerebral edema
    • Kallenberg K, Dehnert C, Dörfler A, et al. Microhemorrhages in nonfatal high-altitude cerebral edema. J Cereb Blood Flow Metab 2008;28:1635-42.
    • (2008) J Cereb Blood Flow Metab , vol.28 , pp. 1635-1642
    • Kallenberg, K.1    Dehnert, C.2    Dörfler, A.3
  • 16
    • 0036569777 scopus 로고    scopus 로고
    • Pathogenesis of high-altitude pulmonary edema: Inflammation is not an etiologic factor
    • Swenson ER, Maggiorini M, Mongovin S, et al. Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA 2002;287:2228-35.
    • (2002) JAMA , vol.287 , pp. 2228-2235
    • Swenson, E.R.1    Maggiorini, M.2    Mongovin, S.3
  • 17
    • 34147108798 scopus 로고    scopus 로고
    • Travel to high altitude with pre-existing lung disease
    • DOI 10.1183/09031936.00052606
    • Luks AM, Swenson ER. Travel to high altitude with pre-existing lung disease. Eur Respir J 2007;29:770-92. (Pubitemid 46554629)
    • (2007) European Respiratory Journal , vol.29 , Issue.4 , pp. 770-792
    • Luks, A.M.1    Swenson, E.R.2
  • 18
    • 77952127474 scopus 로고    scopus 로고
    • High-altitude exposure in patients with cardiovascular disease: Risk assessment and practical recommendations
    • Rimoldi SF, Sartori C, Seiler C, et al. High-altitude exposure in patients with cardiovascular disease: risk assessment and practical recommendations. Prog Cardiovasc Dis 2010;52:512-24.
    • (2010) Prog Cardiovasc Dis , vol.52 , pp. 512-524
    • Rimoldi, S.F.1    Sartori, C.2    Seiler, C.3
  • 19
    • 0023805351 scopus 로고
    • Caractéristiques physiologiques des alpinistes de haute altitude
    • Richalet J-P, Keromes A, Dersch B, et al. Caractéristiques physiologiques des alpinistes de haute altitude. Sci Sports 1988;3:89-108.
    • (1988) Sci Sports , vol.3 , pp. 89-108
    • Richalet, J.-P.1    Keromes, A.2    Dersch, B.3
  • 20
    • 5644277896 scopus 로고    scopus 로고
    • O2 values during short-term exposure to hypoxia
    • DOI 10.1089/1527029042002817
    • Burtscher M, Flatz M, Faulhaber M. Prediction of susceptibility to acute mountain sickness by SaO2 values during short-term exposure to hypoxia. High Alt Med Biol 2004;5:335-40. (Pubitemid 39369234)
    • (2004) High Altitude Medicine and Biology , vol.5 , Issue.3 , pp. 335-340
    • Burtscher, M.1    Flatz, M.2    Faulhaber, M.3
  • 21
    • 14744287627 scopus 로고    scopus 로고
    • Identification of individuals susceptible to high-altitude pulmonary oedema at low altitute
    • DOI 10.1183/09031936.05.00070404
    • Dehnert C, Grünig E, Mereles D, von Lennep N, Bärtsch P. Identification of individuals susceptible to high-altitude pulmonary oedema at low altitude. Eur Respir J 2005;25:545-51. (Pubitemid 40331187)
    • (2005) European Respiratory Journal , vol.25 , Issue.3 , pp. 545-551
    • Dehnert, C.1    Grunig, E.2    Mereles, D.3    Von, L.N.4    Bartsch, P.5
  • 22
    • 65349136490 scopus 로고    scopus 로고
    • Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: Results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia
    • Grünig E, Weissmann S, Ehlken N, et al. Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia. Circulation 2009;119:1747-57.
    • (2009) Circulation , vol.119 , pp. 1747-1757
    • Grünig, E.1    Weissmann, S.2    Ehlken, N.3
  • 24
    • 84866691999 scopus 로고    scopus 로고
    • Clinician's corner: What do we know about safe ascent rates at high altitude?
    • Luks AM. Clinician's corner: what do we know about safe ascent rates at high altitude? High Alt Med Biol 2012;13:147-52.
    • (2012) High Alt Med Biol , vol.13 , pp. 147-152
    • Luks, A.M.1
  • 26
    • 70349514806 scopus 로고    scopus 로고
    • Effect of six days of staging on physiologic adjustments and acute mountain sickness during ascent to 4300 meters
    • Beidleman BA, Fulco CS, Muza SR, et al. Effect of six days of staging on physiologic adjustments and acute mountain sickness during ascent to 4300 meters. High Alt Med Biol 2009;10:253-60.
    • (2009) High Alt Med Biol , vol.10 , pp. 253-260
    • Beidleman, B.A.1    Fulco, C.S.2    Muza, S.R.3
  • 27
    • 77954695609 scopus 로고    scopus 로고
    • Training in normobaric hypoxia and its effects on acute mountain sickness after rapid ascent to 4559 m
    • Schommer K, Wiesegart N, Menold E, et al. Training in normobaric hypoxia and its effects on acute mountain sickness after rapid ascent to 4559 m. High Alt Med Biol 2010;11:19-25.
    • (2010) High Alt Med Biol , vol.11 , pp. 19-25
    • Schommer, K.1    Wiesegart, N.2    Menold, E.3
  • 28
    • 84866273067 scopus 로고    scopus 로고
    • Short-term intermittent hypoxia reduces the severity of acute mountain sickness
    • Wille M, Gatterer H, Mairer K, et al. Short-term intermittent hypoxia reduces the severity of acute mountain sickness. Scand J Med Sci Sports 2012;22(5):e79-e85.
    • (2012) Scand J Med Sci Sports , vol.22 , Issue.5
    • Wille, M.1    Gatterer, H.2    Mairer, K.3
  • 29
    • 79551565644 scopus 로고    scopus 로고
    • Effect of repeated normobaric hypoxia exposures during sleep on acute mountain sickness, exercise performance, and sleep during exposure to terrestrial altitude
    • Fulco CS, Muza SR, Beidleman BA, et al. Effect of repeated normobaric hypoxia exposures during sleep on acute mountain sickness, exercise performance, and sleep during exposure to terrestrial altitude. Am J Physiol Regul Integr Comp Physiol 2011;300:R428-R436.
    • (2011) Am J Physiol Regul Integr Comp Physiol , vol.300
    • Fulco, C.S.1    Muza, S.R.2    Beidleman, B.A.3
  • 30
    • 77954933635 scopus 로고    scopus 로고
    • Altitude preexposure recommendations for inducing acclimatization
    • Muza SR, Beidleman BA, Fulco CS. Altitude preexposure recommendations for inducing acclimatization. High Alt Med Biol 2010;11:87-92.
    • (2010) High Alt Med Biol , vol.11 , pp. 87-92
    • Muza, S.R.1    Beidleman, B.A.2    Fulco, C.S.3
  • 31
    • 0032481792 scopus 로고    scopus 로고
    • Aspirin for prophylaxis against headache at high altitudes: Randomised, double blind, placebo controlled trial
    • Burtscher M, Likar R, Nachbauer W, Philadelphy M. Aspirin for prophylaxis against headache at high altitudes: randomised, double blind, placebo controlled trial. BMJ 1998;316:1057-8. (Pubitemid 28143103)
    • (1998) British Medical Journal , vol.316 , Issue.7137 , pp. 1057-1058
    • Burtscher, M.1    Likar, R.2    Nachbauer, W.3    Philadelphy, M.4
  • 32
    • 84869496350 scopus 로고    scopus 로고
    • Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): Randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness
    • Gertsch JH, Corbett B, Holck PS, et al. Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness. Wilderness Environ Med 2012;23:307-15.
    • (2012) Wilderness Environ Med , vol.23 , pp. 307-315
    • Gertsch, J.H.1    Corbett, B.2    Holck, P.S.3
  • 33
    • 84861529922 scopus 로고    scopus 로고
    • Ibuprofen prevents altitude illness: A randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories
    • Lipman GS, Kanaan NC, Holck PS, Constance BB, Gertsch JH. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories. Ann Emerg Med 2012;59:484-90.
    • (2012) Ann Emerg Med , vol.59 , pp. 484-490
    • Lipman, G.S.1    Kanaan, N.C.2    Holck, P.S.3    Constance, B.B.4    Gertsch, J.H.5
  • 34
    • 33846998654 scopus 로고    scopus 로고
    • High-altitude gastrointestinal bleeding: An observation in Qinghai-Tibetan railroad construction workers on Mountain Tanggula
    • Wu T-Y, Ding S-Q, Liu J-L, et al. High-altitude gastrointestinal bleeding: an observation in Qinghai-Tibetan railroad construction workers on Mountain Tanggula. World J Gastroenterol 2007;13:774-80.
    • (2007) World J Gastroenterol , vol.13 , pp. 774-780
    • Wu, T.-Y.1    Ding, S.-Q.2    Liu, J.-L.3
  • 35
    • 84868327829 scopus 로고    scopus 로고
    • Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: Systematic review and meta-analysis
    • Low EV, Avery AJ, Gupta V, Schedlbauer A, Grocott MP. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis. BMJ 2012;345:e6779.
    • (2012) BMJ , vol.345
    • Low, E.V.1    Avery, A.J.2    Gupta, V.3    Schedlbauer, A.4    Grocott, M.P.5
  • 37
    • 0037367823 scopus 로고    scopus 로고
    • Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: A prospective, double-blind, randomized, placebo-controlled trial
    • Basnyat B, Gertsch JH, Johnson EW, Castro-Marin F, Inoue Y, Yeh C. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial. High Alt Med Biol 2003;4:45-52. (Pubitemid 36511798)
    • (2003) High Altitude Medicine and Biology , vol.4 , Issue.1 , pp. 45-52
    • Basnyat, B.1    Gertsch, J.H.2    Johnson, E.W.3    Castro-Marin, F.4    Inoue, Y.5    Yeh, C.6
  • 38
    • 40549122976 scopus 로고    scopus 로고
    • Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness
    • DOI 10.1089/ham.2007.1037
    • Kayser B, Hulsebosch R, Bosch F. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness. High Alt Med Biol 2008;9:15-23. (Pubitemid 351363932)
    • (2008) High Altitude Medicine and Biology , vol.9 , Issue.1 , pp. 15-23
    • Kayser, B.1    Hulsebosch, R.2    Bosch, F.3
  • 39
    • 0023624163 scopus 로고
    • A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis
    • DOI 10.1016/0002-9343(87)90937-5
    • Ellsworth AJ, Larson EB, Strickland D. A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis. Am J Med 1987;83:1024-30. (Pubitemid 18098873)
    • (1987) American Journal of Medicine , vol.83 , Issue.6 , pp. 1024-1030
    • Ellsworth, A.J.1    Larson, E.B.2    Strickland, D.3
  • 40
    • 0024575075 scopus 로고
    • Effects of dexamethasone on the incidence of acute mountain sickness at two intermediate altitudes
    • DOI 10.1001/jama.261.5.734
    • Montgomery AB, Luce JM, Michael P, Mills J. Effects of dexamethasone on the incidence of acute mountain sickness at two intermediate altitudes. JAMA 1989;261:734-6. (Pubitemid 19047322)
    • (1989) Journal of the American Medical Association , vol.261 , Issue.5 , pp. 734-736
    • Montgomery, A.B.1    Luce, J.M.2    Michael, P.3    Mills, J.4
  • 42
    • 33750115180 scopus 로고    scopus 로고
    • Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: A randomized trial
    • Maggiorini M, Brunner-La Rocca H-P, Peth S, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med 2006;145:497-506.
    • (2006) Ann Intern Med , vol.145 , pp. 497-506
    • Maggiorini, M.1    Brunner-La Rocca, H.-P.2    Peth, S.3
  • 45
    • 77955723079 scopus 로고    scopus 로고
    • Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness
    • Luks AM, McIntosh SE, Grissom CK, et al. Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness Environ Med 2010;21:146-55.
    • (2010) Wilderness Environ Med , vol.21 , pp. 146-155
    • Luks, A.M.1    McIntosh, S.E.2    Grissom, C.K.3
  • 46
    • 0023199354 scopus 로고
    • Successful treatment of acute mountain sickness with dexamethasone
    • Ferrazzini G, Maggiorini M, Kriemler S, Bärtsch P, Oelz O. Successful treatment of acute mountain sickness with dexamethasone. Br Med J (Clin Res Ed) 1987;294:1380-2. (Pubitemid 17078939)
    • (1987) British Medical Journal , vol.294 , Issue.6584 , pp. 1380-1382
    • Ferrazzini, G.1    Maggiorini, M.2    Kriemler, S.3
  • 49
    • 0025671936 scopus 로고
    • High altitude pulmonary edema after successful treatment of acute mountain sickness with dexamethasone
    • Bärtsch P, Vock P, Franciolli M. High altitude pulmonary edema after successful treatment of acute mountain sickness with dexamethasone. Wilderness Environ Med 1990;1:162-4.
    • (1990) Wilderness Environ Med , vol.1 , pp. 162-164
    • Bärtsch, P.1    Vock, P.2    Franciolli, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.